Related Experiment Videos
The past, present and future of transgenic bioreactors
1J. Holland Laboratory, American Red Cross, Rockville, MD, USA. drohan@usa.redcross.org
Thrombosis and Haemostasis
|July 1, 1997
Abstract:
Hybrid genes can control the tissue-specific synthesis of human proteins in transgenic animals. Thus, it is now possible to produce proteins of biomedical value in the body fluids or cells of transgenic livestock. In fact, the first transgenically produced protein, antithrombin III, is now in clinical trials and others will soon follow.